Source: Pharmabiz

iMedX: iMedX completes acquisition of Prevalent and Axcension

iMedX, Inc, an international leader in revenue cycle management, medical documentation, and health information solutions, has successfully completed the acquisition of Prevalent, Inc and Axcension,

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Christopher Foley's photo - Chairman & CEO of iMedX

Chairman & CEO

Christopher Foley

CEO Approval Rating

76/100

Read more